Example security pages for checking stock price, dividend, exchange, ISIN, and CUSIP data after screening.
| Ticker | ISIN | Type | Sector | Industry | Exchange | Country | Currency | Yield (%) | Yield 1Y (%) | Yield 3Y (%) | Yield 5Y (%) | Yield 10Y (%) | Dividend CAGR 1Y (%) | Dividend CAGR 3Y (%) | Dividend CAGR 5Y (%) | Growth Streak | Freq | P/E | Payout (%) | EPS | Market Cap | Book | P/B | Beta | Next Earnings | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() NVS Novartis AG Sponsored ADR | US66987V1098 | EQUITY | Healthcare | Drug Manufacturers - General | NYSE | United States | $ | 3.16 | 3.16 | 2.17 | 1.89 | 1.79 | 83.85 | 14.58 | 2.12 | 4 | Annual | 21.04 | 35.6% | 7.3 | 281.5B | 23.103 | 6.01 | 0.12596728 | N/A | |
![]() NVO Novo Nordisk A/S Sponsored ADR | US6701002056 | EQUITY | Healthcare | Drug Manufacturers - General | NYSE | United States | $ | 5.68 | 4.14 | 3.27 | 2.78 | 2.10 | 15.32 | 26.08 | 16.00 | 7 | Biannually | 10.78 | 33.6% | 3.67 | 280.9B | 6.0361595 | 8.71 | 0.13350076 | N/A | |
![]() MRK Merck & Co., Inc. | US58933Y1055 | EQUITY | Healthcare | Drug Manufacturers - General | NYSE | United States | $ | 2.50 | 2.47 | 2.36 | 2.24 | 1.89 | -48.12 | -0.84 | 5.33 | 4 | Quarterly | 31.72 | 43.4% | 7.56 | 268.5B | 20.845 | 5.11 | 0.5497037 | 2026-10-28 | |
![]() 1MRKX.XMIL Merck & Co., Inc. | EQUITY | Healthcare | Drug Manufacturers - General | MTA | Italy | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 34.75 | 93.5% | 0.0 | 262.6B | 15.98403 | 6.65 | 0.0 | N/A | ||||||||
![]() NOVN.XSWX Novartis AG | CH0012005267 | EQUITY | Health Care | Drug Manufacturers - General | SIX | Switzerland | 2.92 | 2.92 | 2.77 | 2.65 | 2.46 | 0.00 | 0.00 | 0.00 | Annual | 24.03 | 69.9% | 0.0 | 246.6B | 16.251993 | 7.98 | 0.0 | N/A | |||
![]() AMGN Amgen Inc. | US0311621009 | EQUITY | Healthcare | Drug Manufacturers - General | NASDAQ | United States | $ | 2.40 | 2.34 | 2.21 | 2.07 | 1.67 | -21.38 | 4.36 | 8.15 | 15 | Quarterly | 23.40 | 74.7% | 12.93 | 185.6B | 17.863 | 18.56 | 0.39106707 | N/A | |
![]() GILD Gilead Sciences, Inc. | US3755581036 | EQUITY | Healthcare | Drug Manufacturers - General | NASDAQ | United States | $ | 3.00 | 0.00 | 0.00 | 0.00 | Quarterly | 19.45 | 48.6% | 6.46 | 155.9B | 17.343 | 7.25 | 0.331 | N/A | ||||||
![]() AMGD.BCXE Amgen Inc. | EQUITY | Healthcare | Drug Manufacturers - General | CBOE | United Kingdom | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 23.04 | 67.2% | 0.0 | 153.6B | 14.782405 | 19.28 | 0.0 | N/A | ||||||||
![]() GISD.BCXE Gilead Sciences, Inc. | EQUITY | Healthcare | Drug Manufacturers - General | CBOE | United Kingdom | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 18.83 | 43.4% | 0.0 | 147.7B | 15.806072 | 7.53 | 0.0 | N/A | ||||||||
![]() BAY.XWAR Bayer Aktiengesellschaft | EQUITY | Healthcare | Drug Manufacturers - General | GPW | Poland | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 0.00 | 0.0% | 0.0 | 142.4B | 29.361 | 4.94 | 0.0 | N/A |